| Fund ID | 805-9714419107 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 75% |
| Owned by funds of funds | 74% |
| Owned by non-U.S. persons | 25% |
| Fund | Type | Gross assets |
|---|---|---|
| Fmr Capital Holdings LLC | Private Equity | $2.06B |
| Impresa Fund III LP | Private Equity | $1.97B |
| Impresa Fund IV LLC | Private Equity | $700.9M |
F-Prime Capital Partners Life Sciences Fund Vi-B LP reports $10.6 million in gross assets, among the top 77% of private funds by size.
F-Prime Capital Partners Life Sciences Fund Vi-B LP is managed by Impresa Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.